Chris Schelling
2017
In 2017, Chris Schelling earned a total compensation of $585.5K as President and Chief Executive Officer at Opexa Therapeutics.
Compensation breakdown
Option Awards | $468,791 |
---|---|
Salary | $116,667 |
Total | $585,458 |
Schelling received $468.8K in option awards, accounting for 80% of the total pay in 2017.
Schelling also received $116.7K in salary.
Rankings
In 2017, Chris Schelling's compensation ranked 11,280th out of 14,666 executives tracked by ExecPay. In other words, Schelling earned more than 23.1% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 11,280 | 23rd |
Manufacturing | 4,421 | 23rd |
Chemicals And Allied Products | 1,606 | 23rd |
Drugs | 1,323 | 24th |
Pharmaceutical Preparations | 1,033 | 22nd |
Schelling's colleagues
We found four more compensation records of executives who worked with Chris Schelling at Opexa Therapeutics in 2017.
News
Opexa Therapeutics CEO Chris Schelling's 2022 pay jumps 51% to $834K
April 14, 2023
Opexa Therapeutics Chief Business Officer Jefferson Davis receives $635K in 2021
April 15, 2022
Opexa Therapeutics CEO Chris Schelling's 2020 pay falls 54% to $676K
April 16, 2021
Opexa Therapeutics CEO Chris Schelling's 2019 pay jumps 167% to $1.5M
October 14, 2020
Opexa Therapeutics CEO Chris Schelling's 2018 pay slips 6% to $550K
April 12, 2019